Business

Baird Medical Expands Global Reach with Regulatory Clearance in Argentina

NEW YORK, March 12, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in

articleBaird Medical Investment Holdings LtdMarch 12, 20263/company/baird-medical-investment-holdings-limited/news/baird-medical-expands-global-reach-with-regulatory-clearance-in-argentina-8
Baird Medical Expands Global Reach with Regulatory Clearance in Argentina

About this update from Baird Medical Investment Holdings Ltd

[{"type":"text","content":"NEW YORK, March 12, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (\"Baird Medical\" or the \"Company\"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the regulatory clearance of its systems in Argentina. This milestone drives the Company's international growth, supporting a broader mission to expand patient access to highly effective, minimally invasive therapies worldwide.\n \n \n \n \n \n \n \nThe Argentine approval strengthens Baird Medical's growing portfolio of international certifications, which includes the United States FDA, Indonesia, Malaysia, and Vietnam. Building on this progress, the Company is actively seeking formal registration across several major regions. With applications currently under review in Egypt, Sri Lanka, the Philippines, Pakistan, and other key international markets, Baird Medical is steadily advancing its regulatory pipeline to meet rising global demand. This continued expansion ensures that healthcare providers worldwide are equipped with the advanced tools needed to address a wide variety of soft tissue conditions.About Baird Medical Baird Medical is a forward-thinking medical device company specializing in minimally invasive diagnostics and treatment. It is dedicated to the research and development of surgical robotic systems and innovative minimally invasive surgical instruments. Our mission is to enhance patient outcomes through precision technology and advanced diagnostic solutions. The company will foster strategic collaborations with leading academic institutions. Our vision extends beyond surgical assistance, aiming to develop intelligent systems that proactively guide diagnostic decisions and preventive healthcare strategies. As an FDA 510(k)-certified medical device company, Baird Medical's solutions have been used in over 30 prestigious hospitals and clinics across the United States, including Mayo Clinic, Tulane Medical Center, Columbia University Medical Center, UCSF Medical Center, Weill Cornell Medical Center, and The George Washington University Hospital. Baird Medical is also the market leader in China in thyroid microwave ablation devices and consumables. Meanwhile, the company's minimally invasive treatment products are gradually expanding their commercial presence in over 20 countries worldwide.Forward-...

More updates from Baird Medical Investment Holdings Ltd